help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-105-1-27
Endocrinology Vol. 105, No. 1 27-32
Copyright © 1979 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROOS, B. A.
Right arrow Articles by LAMBERT, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROOS, B. A.
Right arrow Articles by LAMBERT, P. W.

Tumor Growth and Calcitonin during Serial Transplantation of Rat Medullary Thyroid Carcinoma*

B. A. ROOS, M. J. YOON, A. L. FRELINGER, A. E. PENSKY, R. S. BIRNBAUM and P. W. LAMBERT

Endocrinology and Mineral Metabolism, Veterans Administration Medical Center and School of Medicine, Case Western Reserve University Cleveland, Ohio 44106

Address requests for reprints to: Dr. Bernard A. Roos, Endocrinology and Mineral Metabolism, Veterans Administration Hospital, 10701 East Boulevard, Cleveland, Ohio 44106.

Abstract

We have recently reported immunochemical methods for the measurement and purification of rat calcitonin (CT). To identify a convenient source of CT-producing cells for studies of rat CT biosynthesis, we have propagated 16 transplantable series of medullary thyroid carcinoma (MTC) from 2 types of WAG/Rij rat MTC from The Netherlands. Tumor CT concentrations and growth and plasma CT accumulation were studied in successive transplant generations of each MTC series. Although most MTC series maintained characteristic predictable tumor CT levels, some MTC series acquired nearly 90% lower CT levels. While related MTC series tended to maintain similar predictable growth rates, several spontaneous and propagatable increases (up to 5-fold) in tumor growth rates were noted. These increases occurred with and without concomitant decreases in tumor CT. Tumor CT production ranged over 20- fold among these 16 MTC series. Serial plasma CT analyses can be used to estimate tumor growth and CT production in live MTC rats. Using serial plasma CT analyses, we can select for serial transplantation tumors with specific growth and CT characteristics. This should facilitate propagation of MTC series needed for particular studies of CT production and cancer.

Footnotes

* This work was supported by the American Cancer Society (BC- 282) and in part by the V.A. and NIH.

Received December 15, 1978.




This article has been cited by other articles:


Home page
ScienceHome page
M. Rosenfeld, S. Amara, and R. Evans
Alternative RNA processing: determining neuronal phenotype
Science, September 21, 1984; 225(4668): 1315 - 1320.
[Abstract] [PDF]


Home page
ScienceHome page
J. Jacobs, R. Goodman, W. Chin, P. Dee, J. Habener, N. Bell, and J. Potts Jr
Calcitonin messenger RNA encodes multiple polypeptides in a single precursor
Science, July 24, 1981; 213(4506): 457 - 459.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1979 by The Endocrine Society